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Abstract
Analbuminemia is a rare autosomal recessive disorder manifested by the absence or severe reduction of circulating serum
albumin in homozygous subjects. In this report we describe a new molecular defect that caused the analbuminemic trait in a
newborn of Iraqi origin. When the parents’ DNA was analyzed, both subjects were found to be heterozygous for the same
mutation found in the infant. All the 14 exon and flanking intron sequences of the albumin gene were amplified via PCR and
screened for mutations by SSCP and heteroduplex analysis. A mutation in the DNA region encoding exon 1 and its flanking
intron was revealed by the presence of a heteroduplex. The fragment, which was directly DNA sequenced, contains a
previously unreported single nucleotide change, consisting in a G to A substitution at nucleotide 118 in the structural gene of
the human protein. This mutation, involving the first base of intron 1, destroys the GT dinucleotide consensus sequence
found at the 5P end of most intervening sequences and causes the defective pre-mRNA splicing responsible for the
analbuminemic trait. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Analbuminemia is a rare autosomal recessive dis-
order in which albumin, normally accounting for
about 60% of the total serum proteins, becomes in
some cases barely detectable and in others appears to
be completely absent from the electrophoretic pat-
tern of homozygous subjects. The condition is con-
ventionally de¢ned by the presence of a plasma al-
bumin level of less than 1 g/l [1], although this value
is below the lower limit that can be accurately quan-
ti¢ed by the most commonly used assays in clinical
laboratories [2]. The ¢rst case of analbuminemia was
reported in 1954 [3], and to date a total of 30 cases
have been described in 26 families [1]. When genea-
logical records became available, consanguinity
among the ancestors of the probands was found to
be a common feature. Despite the fact that albumin
is the most abundant serum protein and has many
important functions the condition is relatively benign
and in several cases it was detected in adults after a
checkup for an unrelated complaint by routine clin-
ical electrophoretic analysis [4]. A signi¢cant increase
in the plasma protein fractions, except for IgG and
IgA, has been observed in all analbuminemic individ-
0925-4439 / 02 / $ ^ see front matter ß 2002 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 0 1 ) 0 0 0 8 4 - 9
* Corresponding author. Fax: +39-382-423108.
E-mail address: galliano@unipv.it (M. Galliano).
BBADIS 62069 18-12-01 Cyaan Magenta Geel Zwart
Biochimica et Biophysica Acta 1586 (2002) 43^49
www.bba-direct.com
uals [5] and has been interpreted as due to a com-
pensatory mechanism. This fact, together with the
low blood pressure characteristic of the disease,
may explain the mild symptoms that most of the
patients present such as slight edema and fatigue.
A constant feature in analbuminemic patients is
also gross hyperlipemia, which is considered second-
ary to the severe albumin level reduction, and con-
sists of L-lipoprotein and total cholesterol values well
above the upper limits [6], although atherosclerosis
and arterial disease do not appear to be more fre-
quent than in the general population and even lon-
gevity seems to be little a¡ected [1]. In contrast to
these relatively mild consequences attributable to the
lack of albumin in adults, the records of several anal-
buminemic families indicate that the disorder is more
severe in the unborn; there are several descriptions
of siblings that died in the neonatal period and of
other pregnancies that resulted in spontaneous abor-
tion [7]. Therefore the rarity of analbuminemia in
humans may re£ect the fact that the lack of albumin
has a deleterious e¡ect on fetal development, and
therefore many, if not most, cases of analbuminemia
do not survive gestation.
The presence of minute amounts of circulating al-
bumin, spanning the range from 0.016 to 1.2 g/l, has
been reported in most homozygous subjects [4] while
heterozygous family members usually have inter-
mediate levels of the plasma protein [1]. The trait
was also found by chance in a Sprague^Dawley rat
[8] and by subsequent breeding experiments the Na-
gase strain of analbuminemic rats was obtained in
which, as for humans, a small amount of circulating
albumin is still detectable. These animals have given
very valuable information on many aspects of the
disease that could not be studied in man [9]. In hu-
mans as well as in rodents analbuminemia is caused
by mutations in the albumin gene which represents a
unique locus within the genome of the two species
[10]. In the Nagase rat the disorder is due to a 7-bp
deletion in intron HI that causes a splicing error [11].
Di¡erent types of defects have been identi¢ed in the
¢ve human families so far analyzed at the molecular
level. A single ACG mutation at nucleotide 7706 in
the 3P acceptor splice site of intron 6 was found to
prevent its removal and to cause the lack of circulat-
ing albumin in an American Indian girl [12,13]. The
insertion of an adenine in exon 8 produced a frame-
shift with the occurrence of a premature termination
codon in analbuminemia Roma [14]. Three point
mutations that generate stop codons at three di¡er-
ent sites have been described in analbuminemia Co-
dogno, in an American female, and in a Canadian
male [7].
Following our studies of mutations on the albumin
gene we describe here the previously unreported mo-
lecular defect, named Baghdad, that is the cause of
analbuminemia in an infant born in Sweden to an
Iraqi mother and father who were found to be het-
erozygotes for the same mutation. The G to A tran-
sition, which inactivates the strongly conserved GT
dinucleotide at the 5P splice site consensus sequence
of the ¢rst intron, causes a defective mRNA splicing
and is therefore responsible for the analbuminemic
trait.
2. Materials and methods
2.1. Patients
The analbuminemic condition was diagnosed in a
male infant born in Sweden, ¢rst child of a mother
and a father from Baghdad, Iraq. He presented with
low birth weight due to placental infarctions and
mild edema was noticed after 1 week. The patient
had no jaundice and his bilirubin level was in the
normal range. The agarose gel electrophoresis of
plasma proteins showed the absence of an albumin
band and only minute amounts of the protein (about
1.1 g/l) were measured with a standard immuno-
chemical method. After 1 week a single infusion of
albumin was administered. At 6 weeks the albumin
level was 10 g/l and lipid levels were normal. At 18
months of age the albumin concentration was less
than 0.5 g/l but a signi¢cant hypercholesterolemia
(9.4 mM) developed in spite of total lipid values
within the normal range. He was in good general
condition, without edema, and he had normal weight
and length for his age.
The parents were ¢rst-degree cousins and other
family members were not available. Both were in
good condition and had a low albumin concentration
value, the father 33 g/l and the mother 27 g/l.
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2.2. Mutation analysis
Genomic DNA was extracted using the QIAamp
Blood Kit (Merck Eurolab) from peripheral blood
samples obtained from the newborn and his parents
after informed consent. Each of the 14 coding exons
of human serum albumin and their intron^exon junc-
tions were PCR-ampli¢ed using speci¢c primer pairs
from genomic DNA of the proband, both parents
and two controls. Primer nucleotide sequences and
conditions were published previously [14] and they
are identi¢able by name. All reactions were per-
formed on a Hybaid thermocycler in a 25-Wl reaction
volume using Ready to Go Beads (Amersham Phar-
macia Biotech, Uppsala, Sweden) with a ¢nal MgCl2
concentration of 1.5 mM. Conditions for ampli¢ca-
tion with primers A01A and A02A included an initial
DNA denaturation at 94‡C for 3 min, followed by 35
cycles of denaturation at 94‡C for 30 s, primer an-
nealing at 58‡C for 30 s and elongation at 72‡C for
30 s. Finally an extension at 72‡C was performed for
3 min. The other primers were used with the same
PCR protocol applying annealing temperatures rang-
ing from 58‡C to 64‡C according to their melting
temperature. The PCR products, which ranged
from 288 to 464 bp in length, gave sharp bands
when checked for homogeneity on a 3% agarose gel
and were directly subjected to mutation screening by
SSCP and heteroduplex analysis.
For SSCP and heteroduplex analysis, PCR prod-
ucts were mixed with equal amounts of SSCP bu¡er
containing 95% formamide, 10 mM NaOH, 0.25%
bromophenol blue and 0.25% xylene cyanol. An ali-
quot of each sample was denatured at 95‡C for 3 min
and cooled on ice before the electrophoretic separa-
tion. Denatured and non-denatured samples were
then loaded on non-denaturing horizontal ultra-¢ne
gels (gel thickness 0.3 mm) composed of 15% acryl-
amide (acrylamide/piperazine diacrylamide 85:1),
7.5% glycerol in 375 mM Tris^formate bu¡er (pH
9.0). The electrodes consisted of paper wicks soaked
in 1.04 M Tris^borate bu¡er (pH 9.0), and the gels
were run in a Pharmacia Multiphore II apparatus at
8‡C for 90 min at 0.8 W/cm [15]. The bands were
visualized by silver staining; brie£y, the gel was
soaked in 1% nitric acid, rinsed in water and then
stained in 0.2% silver nitrate for 20 min. The gel was
rinsed several times with 0.28 M sodium carbonate
containing 0.0175% formaldehyde until bands were
developed (about 10^15 min). Silver staining was
blocked with 5% acetic acid. The 464 bp long PCR
product obtained with primers A01A and A02A was
cleaved with AluI or HincII (Amersham Pharmacia
Biotech) and the resulting restriction fragments were
subjected to SSCP and heteroduplex analysis as de-
scribed above.
In preparation for sequencing reactions the PCR
products obtained with primers A01A and A02A
from genomic DNA of the analbuminemic patient,
the parents and controls were gel-puri¢ed (QIAquick
Gel extraction Kit, Qiagen). Both strands were then
sequenced with the £uorescent dideoxy-termination
method (BigDye Terminator Cycle Sequencing Kit.
Applied Biosystems, Foster City, CA, USA) on an
ABI 310 sequencer (Applied Biosystems) using an
internal primer 5P-TTTGTAATCGGTTGGCAG-
CC-3P(A33M) and primer A02A. Electropherograms
were analyzed with the ABI Prism 310 Data Collec-
tor software.
3. Results and discussion
The DNA samples obtained from the parents of
the analbuminemic infant were screened for muta-
tions by heteroduplex and SSCP analysis as they
were assumed to be heterozygous for the trait on
the basis of their low serum albumin level. All 14
coding exons of the albumin gene encompassing the
intron^exon junctions were ampli¢ed via PCR and
the products were directly analyzed by electrophore-
sis on non-denaturing gels together with two con-
trols. The only detectable di¡erence in the parents
compared to controls was a heteroduplex of the
464-bp PCR product obtained with primers A01A
and A02A (Fig. 1A) encompassing exon 1 and the
exon 1^intron 1 junction. No variation due to con-
formation polymorphism could be seen under these
electrophoretic conditions. In order to improve the
resolution and to localize the mutation within a
shorter DNA region the PCR product was digested
with AluI and HincII and the restriction fragments
obtained were subjected to heteroduplex and SSCP
analysis. The results (Fig. 1B) clearly showed the
same heteroduplex in the 252-bp HincII and in the
189-bp AluI fragments obtained from the DNA of
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the parents when compared with the controls. These
fragments contain the 3P end of exon 1 and the 5P
end of the £anking intron.
The PCR fragment obtained with primers A01A
and A02A from the DNA of the analbuminemic in-
fant, his parents and two controls was sequenced
with the £uorescent dideoxy-termination method.
DNA sequence analysis of this region in the analbu-
minemic patient showed a GCA transition at nucle-
otide 118, the ¢rst base of intron 1 (Fig. 2B). The
parents are clearly heterozygous for the same defect,
as seen in the sequencing electropherograms (Fig.
2C,D) by the presence of the two superimposed
peaks at nucleotide 118 representing the normal
and abnormal base. Thus both parents carry the
wild-type serum albumin allele and the mutant Bagh-
dad allele. It is well established that nearly all splice
sites include invariant dinucleotides at each end of
the intron [16] and that the 14 junctions present in
the human albumin gene conform with the GT and
AG consensus sequences present at the 5P and 3P
exon/intron splice sites, respectively [10]. The point
mutation described here a¡ects pre-mRNA matura-
tion by inactivating the 5P splice site sequence at the
¢rst exon^intron boundary of the albumin gene and
represents a previously unreported genetic defect
causing analbuminemia.
More than 100 hereditary diseases have been cor-
related with errors in pre-mRNA splicing due to mu-
tations involving a consensus sequence and the great
majority of those occurring within the 5P junction
involve the substitution of the +1 G residue by an
Fig. 1. Heteroduplex analysis of exon 1. The DNA encompass-
ing exon 1 and the exon^intron junction from the parents and
two controls was ampli¢ed with primers A01A and A02A and
the fragments were electrophoresed in a non-denaturing polyac-
rylamide gel (A): father lane 1, mother lane 2, controls lanes 3
and 4. The asterisks denote the abnormal heteroduplexes in
lanes 1 and 2. The same samples were denatured and cooled
before loading (father lane 5, mother lane 6, controls lanes 7
and 8). The asterisks denote the abnormal heteroduplex in lanes
5 and 6. (B) The same PCR fragments were analyzed after di-
gestion with HincII (lanes 1^4 and 5^8 non-denatured and de-
natured respectively) or after digestion with AluI (lanes 9^12
and 13^16 non-denatured and denatured respectively). The as-
terisk denotes the abnormal heteroduplex in the 252-bp HincII
fragment (lanes 3^4 and 7^8) and in the 189-bp AluI fragments
(lanes 11^12 and 15^16) obtained from the DNA of the par-
ents.
Fig. 2. Genomic DNA sequence electropherograms of the anal-
buminemic newborn and his parents. (A) Control for the wild-
type sequence. (B) Patient. (C) Mother. (D) Father. Genomic
DNA was prepared as described in Section 2. The arrows indi-
cate the nucleotide that is mutated in the patient: GCA at po-
sition 118, the ¢rst base of intron 1. The patient is homozygous
for this splice site mutation, while both parents are heterozy-
gous for the wild-type and mutated alleles.
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A [17]. This is probably because they are most likely
to result in a severe clinical condition and, therefore,
are readily detectable. Most frequently observed phe-
notypes resulting from such defects are the skipping
of the exon immediately preceding the lesion and the
activation of a cryptic splice site residing close to the
mutated one [17] while the creation of a pseudo-exon
within an intron and intron retention have been de-
scribed in a smaller number of cases [18,19]. It has
been well documented that a point mutation at IVS1
position 1 in a cloned L-thalassemia gene inactivates
the normal splice site and leads to the utilization of
three nearby cryptic, normally inactive, 5P splice sites
within exon 1 which produce a 10^20-fold lower level
of RNA [20]. To identify potential splice sites we
used the tabulated data of Shapiro and Senapathy
[21,22] and no sequence with favorable statistical
scores was identi¢ed within the ¢rst exon and intron
of the albumin gene. The impossibility to obtain liver
RNA from human analbuminemic patients prevents
the characterization of the mRNA they produce and
therefore the consequence of the abolition of the
5P splice site of the ¢rst intron of the Baghdad allele
could not be determined. Among the inherited muta-
tions in the albumin gene a single point substitution
involving the ¢rst base of a donor splice site has been
found to cause a truncated variant named Rugby
Park [23]: the +1 G to C change at the exon 13^
intron 13 boundary abolished the correct splicing
and resulted in the translation of the intron until a
stop codon was reached. Although the protein was
expressed in very low amounts it could be isolated
from the patients’ serum and characterized. The ami-
no acid chain was 578 residues long instead of the
normal 585 of human serum albumin and its C-ter-
minal sequence contained the expected seven new
amino acids. This suggested that the mutation did
not lead to exon skipping but that instead the mature
RNA included the mutated 614 bp long intron with-
out a¡ecting the splicing of introns upstream. The
low level of the variant protein was suggested to be
due to the instability of its precursor mRNA. Con-
sidering the small size of intron 1, 706 bp, the sub-
stitution in the Baghdad allele could have a similar
consequence resulting in the translation of intron 2
up to the ¢rst amber codon, TAA, 50 bp down-
stream. The putative protein product would consist
of only 19 residues, the shortest of any case of anal-
buminemia for which the mutation has been identi-
¢ed at the DNA level, and probably would be rap-
idly degraded intracellularly.
A splicing defect was the cause of the lack of cir-
culating albumin in an American Indian girl. A sin-
gle A to G transition occurring at the penultimate
nucleotide in the acceptor splice site of intron 6 was
shown to prevent the correct splicing in vitro [13].
The e¡ect of the splicing error found in Nagase anal-
buminemic rats and consisting in a 7-bp deletion ex-
tending from bp 5 to 11 at the donor splice site of
intron HI (corresponding to human intron 9) was
examined in more depth [9]. The cytoplasmic
mRNA was markedly reduced and the determination
of its primary structure showed the complete skip-
ping of the exon H sequence. No evidence for an
aberrant protein product was obtained, and the mu-
tated mRNA was believed to be destroyed in the
nucleus. A small proportion of albumin mRNA mol-
ecules with a normal primary structure was identi¢ed
and suggested to be responsible for the production of
the small amount of normal protein observed in
these rats [9].
In addition to splicing mutations, di¡erent mech-
anisms may also cause the defect in humans. The
insertion of a single adenine in the normal AAAA
sequence of nt 9156^9159 caused a frameshift and
introduced a stop codon seven nucleotides down-
stream in analbuminemia Roma. The presence of a
premature termination codon within an exon dis-
rupts coding and results in a poorly secreted or un-
stable protein product [14]. The other three cases of
human analbuminemia resulted from di¡erent point
mutations producing chain termination codons: a
CCT transition at nt 2368 in exon 3 in analbumi-
nemia Codogno, a CCT transition at nt 4446 in
exon 4 for an American case referred to as G.M.,
and a GCA transition at nt 7708, the ¢rst base of
exon 7, in a Canadian male [7]. The size of the trun-
cated albumin that might be produced in these ¢ve
cases of human analbuminemia ranges from 31 to
273 amino acid residues, but no evidence for such
products was obtained.
The protein determination in the ¢rst blood sam-
ple obtained from the newborn homozygous for the
Baghdad allele might have been biased by the high
excess of lipids and, as he was then infused with
albumin, the value of 0.5 g/l obtained at 18 months
BBADIS 62069 18-12-01 Cyaan Magenta Geel Zwart
M. Campagnoli et al. / Biochimica et Biophysica Acta 1586 (2002) 43^49 47
of age represents the protein concentration of the
patient. It is worth noticing that the serum albumin
assays used in clinical laboratories inaccurately mea-
sure the concentration of the protein below the lower
limit of the reference range and therefore may give
misleading results in patients with analbuminemia
[2]. However, the ¢nding that the homozygous new-
born still possesses a small amount of the circulating
protein is in keeping with the reports describing the
other cases of analbuminemia and the Nagase rats.
The subnormal albumin levels of both parents are in
the same range as the other heterozygous individuals
described and can be accounted for by the presence
of a single normal allele. This suggests that the mu-
tated allele produces, if any, only minute amounts of
the normal protein.
The diagnostic relevance of serum albumin levels is
well documented in all clinical textbooks and a rela-
tive or absolute decrease in the circulating protein
values is described as the common feature of almost
every pathological state. In addition large surveys
and several studies, which focused on speci¢c dis-
eases, recognized a signi¢cant positive correlation be-
tween albumin levels and a lower mortality rate.
Therefore a low amount of the plasma protein,
6 40 g/l, is prognostic of a pathological situation
and patients might be subjected to prolonged clinical
tests to ascertain the cause of their disorder. Analbu-
minemia is acquired by inheriting abnormal genes
from both parents and is readily identi¢ed by electro-
phoretic analysis of the plasma proteins while the
heterozygous state leading to severe congenital hypo-
albuminemia is an unrecognized condition. We ex-
pect that studies aimed at identifying the molecular
abnormalities responsible for analbuminemia will
make it possible to use mutation analysis to screen
undiagnosed hypoalbuminemic patients, who appear
to be quite common in clinical practice.
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